Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen IncfiledCriticalAmgen Inc
Publication of AR115312A1publicationCriticalpatent/AR115312A1/es
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
La presente se refiere, en general, a anticuerpos anti-esclerostina que tienen modificaciones C-terminales y a composiciones que comprenden dichos anticuerpos.
ARP190100824A2018-03-302019-03-29Variantes de anticuerpo c-terminales
AR115312A1
(es)